Susquehanna downgraded Viavi from Positive to Neutral and set a new price target of $9.00
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 3/7/2025 | $14.00 | Neutral → Buy | Rosenblatt |
| 1/31/2025 | $15.00 | Hold → Buy | Needham |
| 12/17/2024 | $8.00 → $9.50 | Equal-Weight → Underweight | Morgan Stanley |
| 11/19/2024 | $10.60 | Neutral | UBS |
| 6/26/2024 | $8.25 | Buy → Neutral | Rosenblatt |
| 5/3/2024 | $9.00 | Positive → Neutral | Susquehanna |
| 2/12/2024 | $10.00 → $13.00 | Hold → Buy | Stifel |
| 12/2/2022 | $12.00 | Hold | Stifel |